Vera Therapeutics, Inc. ( VERA) - Key Metrics
VERA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.52 | -$1.40 | -$1.40 |
| 2026Q1 | $0 | -$1.69 | -$1.49 | -$1.49 |
| 2025Q4 | $0 | -$1.42 | -$1.09 | -$1.09 |
| 2025Q3 | $0 | -$1.26 | -$0.97 | -$0.97 |
| 2025Q2 | $0 | -$1.20 | -$0.86 | -$0.86 |
VERA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -7.06 |
| 2026Q1 | 0% | -5.95 |
| 2025Q4 | 0% | -9.11 |
| 2025Q3 | 0% | -5.77 |
| 2025Q2 | 0% | -4.91 |
VERA
Price: $31.63
52 week price:
Earnings Per Share: -5.81 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 367897
Market Capitalization: 2.2 billion